retatrutide company developer The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have FDA Warns Companies Over Compounded

Belal MM, Proceedings (Baylor University Medical Center) (Vol 38, Issue 3, 2025, pp 291303)

The dosage may vary depending on the nutraceutical used

Finally, a recent review by Dayan (2025) demonstrates the need to balance the psychological and ethical considerations in aesthetic medicine, distinguishing between objective beauty and subjective attractiveness while emphasizing the importance of a patients self-confidence in ethical practice [86]

Tirzepatide is a dual action GLP-1 and GIP receptor agonist

Patients should report any new symptoms, including severe persistent abdominal pain (pancreatitis concern), right upper quadrant pain/fever (gallbladder disease), or persistent vomiting/dehydration

L., & Kovacs, E